Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trial
Basch, Ethan, Dr, Autio, Karen, MD, Ryan, Charles J, MD, Mulders, Peter, Prof, Shore, Neal, MD, Kheoh, Thian, PhD, Fizazi, Karim, Prof, Logothetis, Christopher J, Prof, Rathkopf, Dana, MD, Smith, Matthew R, Prof, Mainwaring, Paul N, MD, Hao, Yanni, PhD, Griffin, Thomas, MD, Li, Susan, PhD, Meyers, Michael L, MD, Molina, Arturo, MD, Cleeland, Charles, Prof
Published in The lancet oncology (01.11.2013)
Published in The lancet oncology (01.11.2013)
Get full text
Journal Article